HomeNews

News

Yposkesi launches construction of its second commercial bioproduction site

Yposkesi, a leading Contract Development and Manufacturing Organization (CDMO) specializing in cell and gene therapies, announces the launch of project SKY, the construction of...

Novavax Covid-19 Vaccine demonstrates 90,4% Effective in Late-stage Trial

Biotech company Novavax said that its COVID-19 vaccine is 90.4% effective in a late-stage trial of nearly 30,000 people in the U.S. and Mexico

Global Biopharmaceutical Industry is on track to produce at least 10 billion doses of COVID-19 vaccine by end 2021

Biopharmaceutical industry welcomes COVID-19 vaccine-sharing pledges but warn challenges remain to urgently address vaccine inequity

Leading infectious disease experts in Russia recognized the efficacy of Avifavir

Professor A.V. Devyatkin noted the efficacy of Avifavir® in the combined treatment of patients with COVID-19.

Creating a site for heart disease drug production on the basis of Pharmasyntez-Tyumen

The plant is actively expanding its portfolio and introducing new production facilities. Bilateral cooperation between government and business will continue in the future.

How to Prepare for the Next Pandemic?

It’s is impossible to cope with a pandemic alone. The pandemic knows neither national borders nor state borders. It’s absolutely indifferent to conflicts.
spot_img

Expert Articles

spot_img